SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Dun & Bradstreet Holdings, Inc. (DNB) , forward earnings yield 11.92%. PEG 0.62 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (100/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.62); analyst target implies upside (+109.5%).
- Forward P/E 8.4
- PEG Ratio 0.62 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Analyst consensus target $19.17 (+109.5% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 44/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
17/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — DNB
Valuation Multiples
P/E (TTM)0.0
Forward P/E8.4
PEG Ratio0.62
Forward PEG0.62
P/B Ratio0.00
P/S Ratio1.66
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.07
Forward EPS (Est.)$1.09
Book Value / Share$0.00
Revenue / Share$5.51
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Forward Earnings Yield11.92%
Dividend Yield0.00%
Analyst Target$19.17 (+109.5%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$5.66 |
$1.64B |
$204.2M |
12.5% |
| 2016 |
$2.76 |
$1.7B |
$101.5M |
6% |
| 2017 |
$0.34 |
$1.74B |
$140.9M |
8.1% |
| 2018 |
$0.70 |
$1.72B |
$288.1M |
16.8% |
| 2019 |
$-1.32 |
$1.41B |
$-557.7M |
-39.4% |
| 2020 |
$-0.30 |
$1.74B |
$-108.8M |
-6.3% |
| 2021 |
$-0.16 |
$2.17B |
$-68.6M |
-3.2% |
| 2022 |
$0.00 |
$2.22B |
$1.6M |
0.1% |
| 2023 |
$-0.11 |
$2.31B |
$-47M |
-2% |
| 2024 |
$-0.07 |
$2.38B |
$-28.6M |
-1.2% |
